163 related articles for article (PubMed ID: 29384055)
1. Investigating the Et-1/SphK/S1P Pathway as a Novel Approach for the Prevention of Inflammation-Induced Preterm Birth.
Giusto K; Ashby CR
Curr Pharm Des; 2018; 24(9):983-988. PubMed ID: 29384055
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of sphingosine kinase prevents lipopolysaccharide-induced preterm birth and suppresses proinflammatory responses in a murine model.
Vyas V; Ashby CR; Olgun NS; Sundaram S; Salami O; Munnangi S; Pekson R; Mahajan P; Reznik SE
Am J Pathol; 2015 Mar; 185(3):862-9. PubMed ID: 25579843
[TBL] [Abstract][Full Text] [Related]
3. Exogenous sphingosine 1-phosphate and sphingosine kinase activated by endothelin-1 induced myometrial contraction through differential mechanisms.
Leiber D; Banno Y; Tanfin Z
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C240-50. PubMed ID: 16956968
[TBL] [Abstract][Full Text] [Related]
4. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions.
Yang Y; Torta F; Arai K; Wenk MR; Herr DR; Wong PT; Lai MK
Neurochem Int; 2016 Mar; 94():90-7. PubMed ID: 26921668
[TBL] [Abstract][Full Text] [Related]
6. Signaling pathways involved in sphingosine kinase activation and sphingosine-1-phosphate release in rat myometrium in late pregnancy: role in the induction of cyclooxygenase 2.
Serrano-Sanchez M; Tanfin Z; Leiber D
Endocrinology; 2008 Sep; 149(9):4669-79. PubMed ID: 18723875
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis.
Yang L; Yue S; Yang L; Liu X; Han Z; Zhang Y; Li L
J Hepatol; 2013 Jul; 59(1):114-23. PubMed ID: 23466305
[TBL] [Abstract][Full Text] [Related]
8. Activation of the SPHK/S1P signalling pathway is coupled to muscarinic receptor-dependent regulation of peripheral airways.
Pfaff M; Powaga N; Akinci S; Schütz W; Banno Y; Wiegand S; Kummer W; Wess J; Haberberger RV
Respir Res; 2005 May; 6(1):48. PubMed ID: 15927078
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
Tao R; Zhang J; Vessey DA; Honbo N; Karliner JS
Cardiovasc Res; 2007 Apr; 74(1):56-63. PubMed ID: 17320845
[TBL] [Abstract][Full Text] [Related]
10. Repurposing N,N-Dimethylacetamide (DMA), a Pharmaceutical Excipient, as a Prototype Novel Anti-inflammatory Agent for the Prevention and/or Treatment of Preterm Birth.
Gorasiya S; Mushi J; Pekson R; Yoganathan S; Reznik SE
Curr Pharm Des; 2018; 24(9):989-992. PubMed ID: 29384052
[TBL] [Abstract][Full Text] [Related]
11. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells.
Tauseef M; Kini V; Knezevic N; Brannan M; Ramchandaran R; Fyrst H; Saba J; Vogel SM; Malik AB; Mehta D
Circ Res; 2008 Nov; 103(10):1164-72. PubMed ID: 18849324
[TBL] [Abstract][Full Text] [Related]
12. The endothelin-converting enzyme-1/endothelin-1 pathway plays a critical role in inflammation-associated premature delivery in a mouse model.
Wang W; Yen H; Chen CH; Soni R; Jasani N; Sylvestre G; Reznik SE
Am J Pathol; 2008 Oct; 173(4):1077-84. PubMed ID: 18772340
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate is involved in inflammatory reactions in patients with Graves' orbitopathy.
Seo Y; Chae MK; Han SA; Lee EJ; Lee JH; Yoon JS
Inflamm Res; 2017 Jun; 66(6):535-545. PubMed ID: 28364200
[TBL] [Abstract][Full Text] [Related]
14. Polydatin attenuates AGEs-induced upregulation of fibronectin and ICAM-1 in rat glomerular mesangial cells and db/db diabetic mice kidneys by inhibiting the activation of the SphK1-S1P signaling pathway.
Chen C; Huang K; Hao J; Huang J; Yang Z; Xiong F; Liu P; Huang H
Mol Cell Endocrinol; 2016 May; 427():45-56. PubMed ID: 26948947
[TBL] [Abstract][Full Text] [Related]
15. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases.
Schwalm S; Pfeilschifter J; Huwiler A
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):44-9. PubMed ID: 23789924
[TBL] [Abstract][Full Text] [Related]
16. Building a better sphingosine kinase-1 inhibitor.
Lynch KR
Biochem J; 2012 May; 444(1):e1-2. PubMed ID: 22533672
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.
Maceyka M; Payne SG; Milstien S; Spiegel S
Biochim Biophys Acta; 2002 Dec; 1585(2-3):193-201. PubMed ID: 12531554
[TBL] [Abstract][Full Text] [Related]
18. Prevention of inflammation-associated preterm birth by knockdown of the endothelin-1-matrix metalloproteinase-1 pathway.
Wang W; Yen H; Chen CH; Jasani N; Soni R; Koscica K; Reznik SE
Mol Med; 2010; 16(11-12):505-12. PubMed ID: 20809048
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte sphingosine kinase regulates intraerythrocytic development of Plasmodium falciparum.
Sah RK; Pati S; Saini M; Singh S
Sci Rep; 2021 Jan; 11(1):1257. PubMed ID: 33441957
[TBL] [Abstract][Full Text] [Related]
20. Oxidized LDL-induced angiogenesis involves sphingosine 1-phosphate: prevention by anti-S1P antibody.
Camaré C; Trayssac M; Garmy-Susini B; Mucher E; Sabbadini R; Salvayre R; Negre-Salvayre A
Br J Pharmacol; 2015 Jan; 172(1):106-18. PubMed ID: 25176316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
